The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women
Status:
Completed
Trial end date:
2020-01-02
Target enrollment:
Participant gender:
Summary
A full medical history will be obtained from all participants. Obstetric ultrasonography and
laboratory tests will be performed.According to group assignment, either 1 g(10 mL)
tranexamic acid stored in a dry container at 15 °C-30 °C) diluted in 20 mL of 5% glucose or
30 mL of 5% glucose will be slowly administered intravenously 15 minutes before skin incision
over a 5-minute period.
Following delivery, patients in both groups will receive an intravenous bolus of 5 IU
oxytocin , 1 mL(0.2 mg) intramuscular ergometrine , and 20 IU oxytocin in 500 mL lactated
Ringer's solution(infused at a rate of 125 mL/h)